Molecular diagnosis of endemic and invasive mycoses: Advances and challenges

The diagnosis of endemic and invasive fungal disease remains challenging. Molecular techniques for identification of fungi now play a significant and growing role in clinical mycology and offer distinct advantages as they are faster, more sensitive and more specific. The aim of this mini-review is t...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2014
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23209
Acceso en línea:
https://doi.org/10.1016/j.riam.2013.09.009
https://repository.urosario.edu.co/handle/10336/23209
Palabra clave:
Diagnóstico molecular
Endemic mycosis
Estandarización
Invasive mycoses
Micosis endémicas
Micosis invasivas
Molecular diagnosis
Polymerase chain reaction
Reacción en cadena de la polimerasa
Standardization
Blastomycosis
Coccidioides
Coccidioidomycosis
Endemic Diseases
Humans
Invasive Pulmonary Aspergillosis
Molecular Diagnostic Techniques
Mycology
Mycoses
Paracoccidioides
Paracoccidioidomycosis
Real-Time Polymerase Chain Reaction
Endemic mycosis
Invasive mycoses
Molecular diagnosis
Polymerase chain reaction
Standardization
Invasive
Candidiasis
Rights
License
Abierto (Texto Completo)
Description
Summary:The diagnosis of endemic and invasive fungal disease remains challenging. Molecular techniques for identification of fungi now play a significant and growing role in clinical mycology and offer distinct advantages as they are faster, more sensitive and more specific. The aim of this mini-review is to provide an overview of the state of the art of molecular diagnosis of endemic and invasive fungal diseases, and to emphasize the challenges and current need for standardization of the different methods. The European Aspergillus PCR Initiative (EAPCRI) has made significant progress in developing a standard for Aspergillus polymerase chain reaction (PCR), but recognizes that the process will not be finished until clinical utility has been established in formal and extensive clinical trials. Similar efforts should be implemented for the diagnosis of the other mycoses in order to fully validate the current methods or reinforce the need to design new ones.This manuscript is part of the series of works presented at the 'V International Workshop: Molecular genetic approaches to the study of human pathogenic fungi' (Oaxaca, Mexico, 2012). © 2013 Revista Iberoamericana de Micología.